The 2 analysts offering 12-month price forecasts for Histogen Inc have a median target of 2.70, with a high estimate of 3.00 and a low estimate of 2.40. The median estimate represents a +468.90% increase from the last price of 0.47.
The current consensus among 2 polled investment analysts is to Buy stock in Histogen Inc. This rating has held steady since August, when it was unchanged from a Buy rating.Move your mouse over past months for detail
Earnings and Sales Forecasts
Earnings per Share -$0.11
Reporting Date Mar 10
Earnings per Share
Move your mouse over a quarter or year to see how estimates have changed over time.